Trial intelligence / Profile preview

Memantine for Delaying Driving Impairment in Mild Alzheimer's Disease

NCT00476008Phase 4Completed

Sponsor
Florida Atlantic University
Start
Jul 2007
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Florida Atlantic University. Started Jul 2007; status: completed.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT00476008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00476008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call